These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 2516634

  • 1. Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates.
    Casey DE.
    Psychopharmacol Bull; 1989; 25(3):457-9. PubMed ID: 2516634
    [Abstract] [Full Text] [Related]

  • 2. Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates.
    Casey DE.
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S55-9. PubMed ID: 7831441
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.
    Coffin VL, Latranyi MB, Chipkin RE.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):769-74. PubMed ID: 2567351
    [Abstract] [Full Text] [Related]

  • 5. The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates.
    Casey DE, Bruhwyler J, Delarge J, Géczy J, Liégeois JF.
    Psychopharmacology (Berl); 2001 Sep; 157(3):228-35. PubMed ID: 11605077
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME, Guthrie SK.
    Pharmacotherapy; 1994 Sep; 14(5):543-60. PubMed ID: 7997388
    [Abstract] [Full Text] [Related]

  • 7. Motor and mental aspects of extrapyramidal syndromes.
    Casey DE.
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():105-14. PubMed ID: 8866772
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes.
    González-Lugo OE, Ceballos-Huerta F, Jiménez-Capdeville ME, Arankowsky-Sandoval G, Góngora-Alfaro JL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec 01; 34(8):1465-71. PubMed ID: 20713114
    [Abstract] [Full Text] [Related]

  • 10. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T, Duffy L, O'brien E, Matsumoto I, Dedova I.
    Behav Brain Res; 2006 Aug 10; 171(2):286-94. PubMed ID: 16697060
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys.
    Casey DE.
    Psychopharmacology (Berl); 1992 Aug 10; 107(1):18-22. PubMed ID: 1534177
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
    Batool F, Haleem DJ.
    Pak J Pharm Sci; 2008 Oct 10; 21(4):411-20. PubMed ID: 18930864
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B.
    J Clin Psychiatry; 1995 Mar 10; 56(3):94-100. PubMed ID: 7883736
    [Abstract] [Full Text] [Related]

  • 17. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O, Haleem DJ, Saify ZS, Kamil N, Obaid R, Ahmed SW.
    Pak J Pharm Sci; 2005 Apr 10; 18(2):23-8. PubMed ID: 16431394
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic involvement in haloperidol-induced catalepsy.
    Neal-Beliveau BS, Joyce JN, Lucki I.
    J Pharmacol Exp Ther; 1993 Apr 10; 265(1):207-17. PubMed ID: 8386235
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.